Lab Automation In Drug DiscoveryMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications
Discover trends, market shifts, and competitive outlooks for the lab automation in drug discovery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Lab Automation In Drug Discovery Market Size from 2025 to 2034?
In recent times, there has been a robust expansion in the market size of lab automation in drug discovery. The market, which is expected to surge from $6.47 billion in 2024 to $6.81 billion in 2025, is projected to register a compound annual growth rate (CAGR) of 5.3%. This growth observed in the historic period is attributable to factors such as the rising complexity in drug discovery, the need for operational efficiency and cost cutbacks, an increasing demand for high-throughput screening, mounting labor expenses, and urgency to hasten the timelines of drug development.
In the coming years, the lab automation in drug discovery market is projected to experience significant expansion, poised to rise to $8.4 billion by 2029, marking a compound annual growth rate (CAGR) of 5.4%. This predicted growth during the forecast period is largely driven by factors such as the broadening drug portfolios of pharmaceutical firms, the escalation in personalized medicine and precision therapeutics, heightened focus on unique diseases and specialized drugs, surging demand for off-site and decentralized clinical trials, and the advent of microfluidics and lab-on-a-chip technologies. Predominant trends in the forecast period consist of the spread of customizable and modular automation solutions, the uptake of cloud-based platforms for data collaboration and management, automation growth in emerging markets, the emergence of virtual drug discovery companies exploiting automation and digital technologies, and the formulation of standardized protocols and interoperable systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Lab Automation In Drug Discovery Market?
The surge in the need for precision medicine is predicted to fuel the expansion of lab automation within the drug discovery market. Precision, or personalized, medicine is a medical treatment and prevention approach that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation expedites research, enhances experimental consistency, and boosts precision medicine and drug discovery procedures’ efficiency, thereby resulting in the development of more efficient medicines and diagnostics tailored to individual patients. For example, as of October 2022, the Personalized Medicine Coalition (PMC), a US-centric organization advocating for the understanding and adoption of personalized medicine, reports that over 75,000 genetic testing products and 300 personalized medicines will be available in the market for individuals with diverse types of cancer, rare genetic diseases, and a variety of chronic and infectious diseases. Consequently, the escalating demand for precision medicine is propelling the expansion of lab automation in the drug discovery market.
Which Primary Segments of the Lab Automation In Drug Discovery Market Are Driving Growth and Industry Transformations?
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp
Which Regions Are Key Players in the Growth of the Lab Automation In Drug Discovery Market?
North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Lab Automation In Drug Discovery Market?
Leading organizations in the lab automation sector of drug discovery are concentrating more on creating advanced solutions, such as rapid idea-to-data solutions, to gain a competitive advantage. A rapid idea-to-data solution is a simplified process or platform that aids individuals or organizations in swiftly transitioning their concepts or ideas into actionable knowledge or data-based outcomes. For example, in April 2022, Strateos Inc., a biotechnology firm based in the US, rolled out a rapid idea-to-data solution for small molecule discovery on its cloud-based lab automation-as-a-service platform. This lab automation tool is tailor-made for small-molecule discovery during drug development. The flexible, scalable Strateos Cloud Lab Automation-as-a-Service Platform features connected robotic automation with 23 workcells and hundreds of devices. The platform supports early lead generation to lead optimization, managed by software architecture that lets users design compounds of interest in the cloud and have them auto-assembled and evaluated using an array of methods like cell-based, biochemical, and structured-activity relationship (SAR) evaluations.
View the full report here:
What Parameters Are Used to Define the Lab Automation In Drug Discovery Market?
Lab automation in drug discovery refers to the use of advanced technologies and robotics to streamline and optimize laboratory processes related to new drug development and research. It is used to significantly enhance the speed and success rate of drug discovery efforts by automating repetitive tasks and integrating advanced instruments and software.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
